This one looks like it is just on the safety testing part, but you could see if you want to volunteer.
http://blogs.terrapinn.com/stem-cells/2011/03/24/stemedica-treats-stroke-patient-stemcells/
Stemedica Cell Technologies, Inc. announced today that it has successfully used adult allogeneic mesenchymal stem cells to treat a stroke patient in a study conducted at the University of California, San Diego (UCSD). A total of 35 patients will be enrolled in the clinical trial.
The goal of this study, led by principle investigator Michael Levy, MD, PhD, FACS, chief of pediatric neurosurgery at Children’s Hospital San Diego (CHSD) and professor of neurological surgery at UCSD, is to determine tolerance and therapeutic outcomes for intravenously-delivered adult allogeneic mesenchymal stem cells and to hopefully pave the way for a new therapeutic category of treatment for ischemic stroke.
“This clinical trial marks a significant achievement in the treatment of debilitating ischemia-related pathologies including ischemic stroke,” said Nikolai Tankovich, MD, PhD, president and chief medical officer of Stemedica. “We believe these specially designed mesenchymal stem cells are able to tolerate, survive and repair ischemic tissues caused by an infarction of the brain, heart, kidney, retina and other organs. In addition, these mesenchymal stem cells are capable of up regulating an array of important genes that are essential for the synthesis of critical proteins involved in recovery.”
More than 800,000 Americans suffer a stroke annually and according to the American Heart Association, stroke is the fourth leading cause of death – costing an estimated $73.7 billion in 2010 for stroke-related medical costs and disability.
Watch this space for more updates on stem cells and stroke treatments!
Learn more about stem cells and their applications at Stem Cells USA & Regenerative Medicine Congress.
Read the full press release from Stemedica here.
http://www.stemedica.com/info/allogeneic-adult-stem-cells/stem-cell-clinical-trials/2011-0324-Stemedica-Treats-First-Patient-with-Ischemic-Allogeneic-Mesenchymal-Stem-Cells.asp
No comments:
Post a Comment